NSIV Newsletter – October 2018 Find out more about: NSIV Member Spotlight –Inovotion InBIA Soft Landings Designation – Update Welcome Erica Pratt, New Lab Manager Tom is our IRONMAN Events, News and Updates Read the
“If I could describe INOVOTION in one sentence,” says Olivier Baverey, INOVOTION’s US representative; “it would be accelerating research in oncology, while minimizing costs and risk.” INOVOTION began operations in 2014, after 5 years of
Beverly-based incubator chosen as only international soft landings center in New England; Offers specialized services to foreign biotech and cleantech companies establishing US operations North Shore InnoVentures (NSIV) earned recognition as part of the global
For patients dealing with anxiety, depression, phobia, and other behavioral illnesses, even going out to see a therapist face-to-face can be a real barrier to treatment. iHope Network recognizes this: multiple studies find no-show rates
NSIV Newsletter – September 2018 Find out more about: Member Spotlight – iHope Network InBIA Soft Landing Designation Awarded New Faces at NSIV Other Highlights Events of Interest Read the newsletter in your browser or open it
NSIV Newsletter – August 2018 NSIV is one of the leading cleantech and biotech incubators in Massachusetts. Learn more about: Member Spotlight – HepatoChem Summer Interns Present Accomplishments NSIV Companies Making News Other News of
Once again, interns working at NSIV impressed us with all they accomplished, both for their companies and personally. At the August InnoVentures U, our summer interns made formal presentations before a group of 30, explaining
HepatoChem was founded as a company for metabolite production, hence the name — “Hepato” refers to the liver, which is the organ responsible for most of metabolism. The company provides a sort “chemical liver” for
July 2018 Find out more about: Getting to Know CEO Chris Ilsley Member Spotlight – Glycologix Five Words – Our Companies Do What? Around the World with NSIV Read the newsletter in your browser or open it as
New NSIV CEO & President, Chris Ilsley (say “ills lee”) has been with us for just over a month. We briefly introduced him to you in last month’s newsletter, but now it’s time for a
This month, we welcome back Glycologix, who recently rejoined NSIV. At Glycologix, what began as a potential cure for wrinkles has evolved into what could become the first treatment on the market for a debilitating
NSIV member company, InsomniSolv, recently won Sanofi’s VivaTech 2018 “Sleep Challenge”, voted the winner over 21 other submissions. Founder, Peter Kelley, is developing a neurostimulator device to mitigate insomnia. Read about the “Sleep Challenge” and
June 2018 Find out more about: Welcome to New NSIV President & CEO Member Spotlight – Genomic Expression New Companies Join NSIV Summer Interns are Here! The World Cup Read the newsletter in your browser or open
Every year, $100 billion goes into standard cancer treatment, prescribed based on the cancer’s stage and tissue of origin. Patients receiving these treatments assume that they are being given the medicine they need, but the
On June 18, 2018, the North Shore InnoVentures board announced the appointment of Chris Ilsley as CEO and President. Ilsley replaces outgoing CEO Martha Farmer who has overseen a decade of growth for the biotech and
May 2018 Find out more about: NSIV is turning 10! Cummings Foundation Awards Ceremony Member Spotlight – CrowdComfort NSIV Spring ’18 Interns Newest Lab Equipment Read the newsletter in your browser or open it as a PDF.
CrowdComfort CrowdComfort started as a simple idea, pitched at the 2013 Boston Cleanweb Hackathon: what if people could use their smartphones to unlock efficiencies in building and workplace management? Since these humble beginnings, CrowdComfort has
April 2018 Find out more about: NSIV Wins Technology Incubator of the Year NSIV Awarded 10-Year Sustaining Grant from Cummings Foundation Member Spotlight – Akita Innovations Sad News from NSIV Headquarters Read the newsletter in your browser or open
Akita Innovations custom synthesizes novel materials and chemicals. Akita develops and sells high-value materials for companies that want an edge on their competitors and government customers who have unique and demanding requirements. Its chemicals and materials
NSIV is thrilled to share the wonderful news that we are receiving a grant from the Cummings Foundation’s new Sustaining Grants Program. The grant will provide NSIV with an annual installment of $20,000 for ten years.
Interested in incubating your company with NSIV? Submit your application today!